Targeting GSK3 from Ustilago maydis: Type-II kinase inhibitors as potential antifungals

ACS Chemical Biology

Volumn 7, Issue 7, 2012, Pages 1257-1267

  Grütter, Christian ^a   Simard, Jeffrey R ^b   Mayer Wrangowski, Svenja C ^a   Schreier, Peter H ^c,d   Pérez Martín, José ^e   Richters, André ^a,b   Getlik, Matthäus ^b   Gutbrod, Oliver ^c   Braun, Christoph A ^c   Beck, Michael E ^c   Rauh, Daniel ^a,b  

^a TU DORTMUND UNIVERSITY   (Germany)

^b CHEMICAL GENOMICS CENTRE OF THE MAX PLANCK SOCIETY   (Germany)

^c BAYER CROPSCIENCE AG   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e Instituto de Biología Funcional y Genómica and Departamento de Microbiología y Genética   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO PYRIMIDINE; 3 (4 BROMO 2,6 DIFLUOROBENZYLOXY) 5 [3 [4 (1 PYRROLIDINYL)BUTYL]UREIDO] 4 ISOTHIAZOLECARBOXAMIDE; ANTIFUNGAL AGENT; DORAMAPIMOD; GLYCOGEN SYNTHASE KINASE 3; IMATINIB; PHOSPHOTRANSFERASE INHIBITOR; PONATINIB; PYRIMIDINE DERIVATIVE; SORAFENIB; UNCLASSIFIED DRUG;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG INHIBITION; DRUG STRUCTURE; DRUG TARGETING; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; USTILAGO MAYDIS; VALIDATION PROCESS; X RAY;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; CRYSTALLOGRAPHY, X-RAY; DRUG DELIVERY SYSTEMS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN KINASE INHIBITORS; USTILAGO;

EUKARYOTA; FUNGI; PROTOZOA; USTILAGO MAYDIS;

EID: 84864124202     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300128b     Document Type: Article

References (42)

1. Doerig, C. (2004) Protein kinases as targets for anti-parasitic chemotherapy Biochim. Biophys. Acta 1697, 155-168
2. Kojima, K., Takano, Y., Yoshimi, A., Tanaka, C., Kikuchi, T., and Okuno, T. (2004) Fungicide activity through activation of a fungal signalling pathway Mol. Microbiol. 53, 1785-1796
3. Pillonel, C. (2005) Evaluation of phenylaminopyrimidines as antifungal protein kinase inhibitors Pest Manage. Sci. 61, 1069-1076
4. Oduor, R. O., Ojo, K. K., Williams, G. P., Bertelli, F., Mills, J., Maes, L., Pryde, D. C., Parkinson, T., Van Voorhis, W. C., and Holler, T. P. (2011) Trypanosoma brucei glycogen synthase kinase-3, a target for anti-trypanosomal drug development: a public-private partnership to identify novel leads PLoS Neglected Trop. Dis. 5, e1017
5. Tückmantel, S., Greul, J. N., Janning, P., Brockmeyer, A., Grütter, C., Simard, J. R., Gutbrod, O., Beck, M. E., Tietjen, K., Rauh, D., and Schreier, P. H. (2011) Identification of Ustilago maydis aurora kinase as a novel antifungal target ACS Chem. Biol. 6, 926-933
6. Koch, A., Rode, H. B., Richters, A., Rauh, D., and Hauf, S. (2012) A chemical genetic approach for covalent inhibition of analogue-sensitive aurora kinase ACS Chem. Biol. 7, 723-731
7. Uitdehaag, J. C., Verkaar, F., Alwan, H., de Man, J., Buijsman, R. C., and Zaman, G. J. (2012) A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets Br. J. Pharmacol. 10.1111/j.1476-5381.2012.01859.x
8. Koeberle, S. C., Romir, J., Fischer, S., Koeberle, A., Schattel, V., Albrecht, W., Grütter, C., Werz, O., Rauh, D., Stehle, T., and Laufer, S. A. (2011) Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor Nat. Chem. Biol. 8, 141-143
9. Rabiller, M., Getlik, M., Klüter, S., Richters, A., Tückmantel, S., Simard, J. R., and Rauh, D. (2010) Proteus in the world of proteins: conformational changes in protein kinases Arch. Pharm. 343, 193-206
10. Hantschel, O., Nagar, B., Guettler, S., Kretzschmar, J., Dorey, K., Kuriyan, J., and Superti-Furga, G. (2003) A myristoyl/phosphotyrosine switch regulates c-Abl Cell 112, 845-857
11. Wu, W. I., Voegtli, W. C., Sturgis, H. L., Dizon, F. P., Vigers, G. P., and Brandhuber, B. J. (2010) Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition PloS One 5, e12913
12. Ojo, K. K., Gillespie, J. R., Riechers, A. J., Napuli, A. J., Verlinde, C. L., Buckner, F. S., Gelb, M. H., Domostoj, M. M., Wells, S. J., Scheer, A., Wells, T. N., and Van Voorhis, W. C. (2008) Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy Antimicrob. Agents Chemother. 52, 3710-3717
13. Martinez, A., Castro, A., Dorronsoro, I., and Alonso, M. (2002) Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation Med. Res. Rev. 22, 373-384
14. Palomo, V., Soteras, I., Perez, D. I., Perez, C., Gil, C., Campillo, N. E., and Martinez, A. (2011) Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities J. Med. Chem. 54, 8461-8470
15. Brachmann, A., Weinzierl, G., Kamper, J., and Kahmann, R. (2001) Identification of genes in the bW/bE regulatory cascade in Ustilago maydis Mol. Microbiol. 42, 1047-1063
16. Pawar, V. G., Sos, M. L., Rode, H. B., Rabiller, M., Heynck, S., van Otterlo, W. A., Thomas, R. K., and Rauh, D. (2010) Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor J. Med. Chem. 53, 2892-2901
17. Rode, H. B., Sos, M. L., Grütter, C., Heynck, S., Simard, J. R., and Rauh, D. (2011) Synthesis and biological evaluation of 7-substituted-1-(3- bromophenylamino)isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase and epidermal growth factor receptor Bioorg. Med. Chem. 19, 429-439
18. Sos, M. L., Rode, H. B., Heynck, S., Peifer, M., Fischer, F., Klüter, S., Pawar, V. G., Reuter, C., Heuckmann, J. M., Weiss, J., Ruddigkeit, L., Rabiller, M., Koker, M., Simard, J. R., Getlik, M., Yuza, Y., Chen, T. H., Greulich, H., Thomas, R. K., and Rauh, D. (2010) Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation Cancer Res. 70, 868-874
19. Getlik, M., Grütter, C., Simard, J. R., Klüter, S., Rabiller, M., Rode, H. B., Robubi, A., and Rauh, D. (2009) Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc J. Med. Chem. 52, 3915-3926
20. Klüter, S., Grütter, C., Naqvi, T., Rabiller, M., Simard, J. R., Pawar, V., Getlik, M., and Rauh, D. (2010) Displacement assay for the detection of stabilizers of inactive kinase conformations J. Med. Chem. 53, 357-367
21. Rodems, S. M., Hamman, B. D., Lin, C., Zhao, J., Shah, S., Heidary, D., Makings, L., Stack, J. H., and Pollok, B. A. (2002) A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases Assay Drug Dev. Technol. 1, 9-19
22. Anastassiadis, T., Deacon, S. W., Devarajan, K., Ma, H., and Peterson, J. R. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity Nat. Biotechnol. 29, 1039-1045
23. Shults, M. D., Janes, K. A., Lauffenburger, D. A., and Imperiali, B. (2005) A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates Nat. Methods 2, 277-283
24. Mayer-Wrangowski, S. (2010) Cloning, Expression and structural Characterization of a fungal Protein Kinase, Master thesis, Technical University of Dortmund, Dortmund, Germany.
25. Matthews, B. W. (1968) Solvent content of protein crystals J. Mol. Biol. 33, 491-497
26. Cole, A., Frame, S., and Cohen, P. (2004) Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event Biochem.l J. 377, 249-255
27. Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F., and Woodgett, J. R. (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation EMBO J. 12, 803-808
28. Simard, J. R., Getlik, M., Grütter, C., Pawar, V., Wulfert, S., Rabiller, M., and Rauh, D. (2009) Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors J. Am. Chem. Soc. 131, 13286-13296
29. Simard, J. R., Klüter, S., Grütter, C., Getlik, M., Rabiller, M., Rode, H. B., and Rauh, D. (2009) A new screening assay for allosteric inhibitors of cSrc Nat. Chem. Biol. 5, 394-396
30. Getlik, M., Grütter, C., Simard, J. R., Nguyen, H. D., Robubi, A., Aust, B., van Otterlo, W. A., and Rauh, D. (2012) Structure-based design, synthesis and biological evaluation of N-pyrazole, Nβ-thiazole urea inhibitors of MAP kinase p38alpha Eur. J. Med. Chem. 48, 1-15
31. Cline, G. W., Johnson, K., Regittnig, W., Perret, P., Tozzo, E., Xiao, L., Damico, C., and Shulman, G. I. (2002) Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats Diabetes 51, 2903-2910
32. Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., and Regan, J. (2002) Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site Nat. Struct. Biol. 9, 268-272
33. Copeland, R. A., Pompliano, D. L., and Meek, T. D. (2006) Drug-target residence time and its implications for lead optimization Nat. Rev. Drug Discovery 5, 730-739
34. Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., and Pearl, L. H. (2001) Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition Cell 105, 721-732
35. Kabsch, W. (1993) Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants J. Appl. Crystallogr. 26, 795-800
36. Read, R. J. (2001) Pushing the boundaries of molecular replacement with maximum likelihood Acta Crystallogr., Sect. D: Biol. Crystallogr. 57, 1373-1382
37. ter Haar, E., Coll, J. T., Austen, D. A., Hsiao, H. M., Swenson, L., and Jain, J. (2001) Structure of GSK3beta reveals a primed phosphorylation mechanism Nat. Struct. Biol. 8, 593-596
38. Emsley, P. and Cowtan, K. (2004) Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 60, 2126-2132
39. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination Acta Crystallogr., Sect. D: Biol. Crystallogr. 54, 905-921
40. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr., Sect. D: Biol. Crystallogr. 53, 240-255
41. Laskowski, R. A., McArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) PROCHECK: a program to check the stereochemical quality of protein structures J. Appl. Crystallogr. 26, 263-291
42. DeLano, W. L. (2002) The PyMOL Molecular Graphics System, http://www.pymol.org.